Theranexus (EPA:ALTHX) | WebDisclosure

BRIEF

published on 05/13/2025 at 18:05, 18 days 3 hours ago

Theranexus and BBDF reveal promising results for Batten-1

Theranexus Batten-1 BBDF Batten Disease Visual Acuity
BRIEF

published on 05/13/2025 at 18:05, 18 days 3 hours ago

Theranexus et BBDF révèlent des résultats prometteurs pour le Batten-1

Theranexus Batten-1 Maladie De Batten BBDF Acuité Visuelle
PRESS RELEASE

published on 05/13/2025 at 18:00, 18 days 3 hours ago

THERANEXUS AND BEYOND BATTEN DISEASE FOUNDATION ANNOUNCE STRONG POSITIVE REAL-WORLD DATA SUPPORTING BATTEN-1 EFFICACY FOR THE TREATMENT OF BATTEN DISEASE
Theranexus and BBDF announce new data supporting Batten-1 (miglustat) efficacy for CLN3 disease treatment. Results show significant preservation of visual acuity in treated patients over 12 months. Real-world analysis aligns with Phase 3 trial design

Theranexus Batten-1 BBDF Visual Acuity CLN3 Disease
PRESS RELEASE

published on 05/13/2025 at 18:00, 18 days 3 hours ago

THERANEXUS ET LA FONDATION BEYOND BATTEN DISEASE ANNONCENT DES DONNÉES EN VIE RÉELLE TRÈS POSITIVES SOUTENANT L'EFFICACITÉ DE BATTEN-1 DANS LE TRAITEMENT DE LA MALADIE DE BATTEN CLN3
Theranexus et la Fondation Beyond Batten Disease présentent des résultats prometteurs pour le traitement de la maladie de Batten-CLN3 avec le médicament Batten-1 (miglustat). Nouvelle étude en vie réelle montre une préservation de l'acuité visuelle

Theranexus Batten-1 Miglustat Fondation Beyond Batten Disease Traitement CLN3
BRIEF

published on 04/29/2025 at 19:05, 1 month 2 days ago

Theranexus : Bilan Annuel 2024 et Nouvelles Perspectives

Résultats Financiers Partenariats Theranexus Batten-1 Subventions
BRIEF

published on 04/29/2025 at 19:05, 1 month 2 days ago

Theranexus: 2024 Annual Review and New Perspectives

Financial Results Partnerships Theranexus Batten-1 Grants
PRESS RELEASE

published on 04/29/2025 at 19:00, 1 month 2 days ago

THERANEXUS PUBLISHES ITS 2024 FULL-YEAR RESULTS, PRESENTS ITS PROGRESS REPORT AND CLOSES ITS EQUITY LINE
Theranexus publishes financial results for 2024 & cash position as of March 31, 2025, presents progress report & plans for Batten-1 drug candidate. Board approves accounts. Continues strategic partnerships & developments

Financial Results Strategic Partnerships Clinical Trials Theranexus Batten-1
PRESS RELEASE

published on 04/29/2025 at 19:00, 1 month 2 days ago

THERANEXUS PUBLIE SES RÉSULTATS ANNUELS 2024, FAIT LE POINT SUR SES ACTIVITÉS ET CLÔTURE SA LIGNE DE FINANCEMENT
Theranexus publie ses résultats annuels 2024, fait le point sur ses activités et clôture sa ligne de financement. Détails sur Batten-1, PickASO, IMASO et partenariat avec Exeltis

Résultats Annuels Theranexus Batten-1 PickASO Exeltis
BRIEF

published on 03/06/2025 at 18:05, 2 months 25 days ago

Modification du contrat de liquidité de Theranexus

Contrat De Liquidité AMF PORTZAMPARC Theranexus Maladies Neurologiques Rares
BRIEF

published on 03/06/2025 at 18:05, 2 months 25 days ago

Modification of the Theranexus liquidity contract

Liquidity Contract AMF PORTZAMPARC Theranexus Rare Neurological Diseases

1 2 ... 9

Published on 05/31/2025 at 06:16, 15 hours 4 minutes ago

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
Published on 05/31/2025 at 03:30, 17 hours 50 minutes ago

Avant Brands Inc. Announces Voting Results From 2025 Annual General Meeting of Shareholders
Published on 05/31/2025 at 01:45, 19 hours 35 minutes ago

GLG Life Tech Corporation Reports 2025 First Quarter Financial Results
Published on 05/30/2025 at 23:10, 22 hours 10 minutes ago

CORRECTION: Nextech3D.ai Migrates MAP Dynamics to AWS, Enabling Scalable AI Architecture and Accelerated Deployment
Published on 05/30/2025 at 23:00, 22 hours 20 minutes ago

Battery X Metals Achieves Full Capacity Recovery on a Real-World Imbalanced Battery from the #2 Out-of-Warranty Electric Vehicle Model in the United States in Preliminary Trial

View all ACCESSWIRE

Published on 05/31/2025 at 21:00, 20 minutes ago

Leclanché annonce le dépôt d'une demande de prolongation du délai de publication du rapport annuel 2024 et la suspension temporaire de la cotation de ses actions nominatives à la SIX Swiss Exchange
Published on 05/31/2025 at 21:00, 20 minutes ago

Leclanché SA: Leclanché announces filing of request to extend the publication deadline for the 2024 Annual Report and the temporary suspension of trading of its registered shares on SIX Swiss Exchange
Published on 05/31/2025 at 18:37, 2 hours 43 minutes ago

Meyer Burger files for insolvency for German subsidiaries
Published on 05/31/2025 at 14:50, 6 hours 29 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/31/2025 at 14:46, 6 hours 34 minutes ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets

View all EQS

Published on 05/30/2025 at 22:00, 23 hours 20 minutes ago

Information sur les comptes annuels
Published on 05/30/2025 at 22:00, 23 hours 20 minutes ago

Information on the Annual Financial Statements
Published on 05/30/2025 at 18:14, 1 day 3 hours ago

Emova Group - Rapport annuel de Durabilité 23/24
Published on 05/28/2025 at 23:00, 2 days 22 hours ago

Standstill Commitments to hold shares of the company
Published on 05/28/2025 at 23:00, 2 days 22 hours ago

Engagements collectifs de conservation de titres de la société

View all LES ECHOS COMFI WIRE

News